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Comparative effectiveness research 
a b s t r a c t 
Objective: : The aim of this manuscript is to compare characteristics, management, and outcomes of pa- 
tients with severe Traumatic Brain Injury (TBI) between Australia, the United Kingdom (UK) and Europe. 
Methods: : We enrolled patients with severe TBI in Victoria, Australia (OzENTER-TBI), in the UK and 
Europe (CENTER-TBI) from 2015 to 2017. Main outcome measures were mortality and unfavourable out- 
come (Glasgow Outcome Scale Extended < 5) 6 months after injury. Expected outcomes were compared 
according to the IMPACT-CT prognostic model, with observed to expected (O/E) ratios and 95% confidence 
intervals. 
Results: : We included 107 patients from Australia, 171 from UK, and 596 from Europe. Compared to the 
UK and Europe, patients in Australia were younger (median 32 vs 44 vs 44 years), a larger proportion had 
secondary brain insults including hypotension (30% vs 17% vs 21%) and a larger proportion received ICP 
monitoring (75% vs 74% vs 58%). Hospital length of stay was shorter in Australia than in the UK (median: 
17 vs 23 vs 16 days), and a higher proportion of patients were discharged to a rehabilitation unit in 
Australia than in the UK and Europe (64% vs 26% vs 28%). Mortality overall was lower than expected (27% 
vs 35%, O/E ratio 0.77 [95% CI: 0.64 – 0.87]. O/E ratios were comparable between regions for mortality 
in Australia 0.86 [95% CI: 0.49–1.23] vs UK 0.82 [0.51–1.15] vs Europe 0.76 [0.60–0.87]). Unfavourable 
outcome rates overall were in line with historic expectations (O/E ratio 1.32 [0.96-1.68] vs 1.13 [0.84- 
1.42] vs 0.96 [0.85-1.09]). 
Conclusions: : There are major differences in case-mix between Australia, UK, and Europe; Australian 
patients are younger and have a higher rate of secondary brain insults. Despite some differences in man- 
agement and discharge policies, mortality was less than expected overall, and did not differ between 
regions. Functional outcomes were similar between regions, but worse than expected, emphasizing the 
need to improve treatment for patients with severe TBI. 
© 2021 The Authors. Published by Elsevier Ltd. 
This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ) 
https://doi.org/10.1016/j.injury.2021.04.033 
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Introduction 
Traumatic Brain Injury (TBI) is a leading cause of death and 
long-term disability, particularly in young adults. Sixty-nine million 
individuals worldwide are estimated to sustain a TBI each year.( 1 ) 
In Australia, TBI accounts for over 10 0 0 Intensive Care Unit (ICU) 
admissions per year.( 2 ) Half of severe TBI patients will be severely 
disabled or dead within six months of the injury, with lifetime 
costs largely due to disabled survivors of an estimated annual hos- 
pital costs of €33 billion of indirect and direct costs in Europe.( 3 , 
4 ) For Australia, the lifetime cost for each severe TBI was estimated 
at $4,8 million.( 5 , 6 ) 
Although recent randomised trials of alternative current ther- 
apies have provided guidance for clinicians (SAFE-TBI, DECRA, 
RESCUEicp, POLAR), trials of new therapies have been generally 
discouraging or require further investigations to resolve uncer- 
tainty.( 7-11 ) Guideline recommendations for TBI care are often 
weak, leaving opportunity for individual treatment preferences and 
resource availability, resulting in variation of care. Comparative ef- 
fectiveness research subsequently has been embraced internation- 
ally, and uses practice variation to measure benefits and risks of 
systems of care and interventions in ordinary settings and broader 
populations, reflecting daily clinical practice.( 12 ) 
An earlier study that compared outcomes following major 
trauma involving serious head injury managed in Victoria, Aus- 
tralia and the UK concluded that the absence of an organized 
trauma system in the UK at that time was associated with in- 
creased risk-adjusted mortality compared to management in the 
inclusive trauma system of Victoria, Australia over these years.( 13 ) 
However, contemporary global comparisons of patients with severe 
TBI have been few, are largely limited to North America and Eu- 
rope, and are hampered by different times, settings and popula- 
tions. Improved understanding of the benefits and limitations of 
different approaches to care for TBI patients requires comparisons 
across trauma care systems, using comparable methods of data 
collection and comparable time periods. Practice variation in the 
management of TBI patients admitted to the ICU might then offer 
opportunities for identification of best practices using comparative 
effectiveness research. 
This study compared demographics, treatment characteristics 
and outcomes in two prospective harmonised cohorts of severe 
TBI patients in the state of Victoria Australia (population 6 million; 
OzENTER), with UK and Europe (CENTER-TBI). 
Methods 
Study population 
Data came from the Collaborative European NeuroTrauma Ef- 
fectiveness Research (CENTER-TBI) Core Study and the OzENTER- 
TBI (Australia-Europe NeuroTrauma Effectiveness Research in Trau- 
matic Brain Injury) Study. Both studies were longitudinal cohort 
studies with harmonised data points and outcome assessments. 
The OzENTER-TBI Study was conducted in the two designated adult 
major trauma centres in Victoria, Australia at different intervals be- 
tween February 2015 to March 2017. These centres receive 85% of 
adults with severe TBI from a state population of 6 million. The 
CENTER-TBI Core study included TBI patients that were admitted 
to the ICU across 54 centres in the European Union, the United 
Kingdom (UK) and Israel between 2015 and 2017. Patients or fam- 
ily were given the opportunity to opt-out of data collection in the 
OzENTER-TBI Study. Ethics approval in the OzENTER-TBI study was 
∗ Corresponding author. 
E-mail address: e.wiegers@erasmusmc.nl (E.J.A. Wiegers). 
granted by Human Research Ethics Committees of the local univer- 
sity, along with the two participating adult major trauma centres. 
The CENTER-TBI Core study was approved by the medical ethics 
committees of all participating centres and consent was obtained 
according to local regulations. More detailed information about the 
CENTER-TBI Core Study can be found in the study protocol and the 
publication of the main results.( 14-16 ) Patients of any age were in- 
cluded if they underwent a CT-scan of the brain and were admitted 
to the ICU within 24 hours of injury. Patients with a pre-existing 
neurological disorder that would otherwise confound outcome as- 
sessment were excluded. For the purpose of the current study, we 
included all patients with severe TBI, which was defined as a Glas- 
gow Coma Scale (GCS) score of 3-8 at baseline that were admitted 
to the ICU. 
Data collection 
Detailed information on demographics, injury characteristics, 
and clinical characteristics was collected. Clinical data was col- 
lected on a daily basis: at ICU admission, during ICU stay (days 1-7, 
day 10, day 14, day 21, and day 28), and at ICU discharge. Data col- 
lection was undertaken by trained Research Coordinators and en- 
tered into an online Case Report Form. CT scans were obtained in 
all patients upon presentation and centrally reviewed. Follow up 
CT scans were acquired as clinically indicated. All patients were 
treated according to local protocol. 
Outcome assessment 
The eight-point Glasgow Outcome Scale Extended (GOSE; over- 
all effect of injury) was collected at 6 months after injury. The 
GOSE was measured by either a postal questionnaire or a struc- 
tured (telephone) interview by a trained assessor.( 17 ) The cate- 
gories ‘vegetative state (GOSE 2)’ and ‘lower severe disability (GOSE 
3)’ were combined resulting in a seven-point ordinal scale. Un- 
favourable outcome was defined as a GOSE < 5, and Favourable out- 
come as a GOSE > 4. 
Statistical analysis 
Patients were stratified into three groups: patients that were 
admitted to a study centre in 1) Australia (OzENTER-TBI Study), 
2) the United Kingdom (CENTER-TBI Study), 3) Europe (CENTER- 
TBI Study). Countries that included less than 50 severe TBI patients 
were omitted from analysis. 
Baseline characteristics were presented as median values with 
interquartile ranges (IQR) for continuous variables and as frequen- 
cies and percentages for categorical variables. ANOVA was used for 
comparison of continuous variables across strata. The χ2 test was 
used for comparison of categorical variables. 
The IMPACT CT model was used to calculate the expected mor- 
tality and expected proportion of patients with unfavourable out- 
come at 6 months in patients with severe TBI.( 18 ) The IMPACT CT 
(International Mission for Prognosis and Analysis of Clinical Tri- 
als in TBI Computed Tomography) model was developed for pre- 
dicting 6 month outcome in adult patients with moderate to se- 
vere head injury using their key covariates. The model was devel- 
oped and validated in collaboration with the CRASH trial collab- 
orations both including large numbers of individual patient data. 
The model discriminates well; and has been validated for the pur- 
pose of classification and characterization of large cohorts of pa- 
tients.( 19 ) Observed to expected (O/E) ratios were calculated with 
95% confidence intervals. We performed a sensitivity analysis of 
the outcome comparison after multiple imputation, with use of 
the mice package in R. All statistical analyses were performed in 
R (version 3.5.1) and RStudio (version 1.0.136). CENTER-TBI data 
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was accessed using a bespoke data management tool, ‘Neurobot’ 
( http://neurobot.incf.org , RRID: SCR_01700), vs 2.0 (data freeze: 
June 2019). 
Results 
In total, 198 patients were included in the OzENTER-TBI Study 
and 2138 patients were included in the CENTER-TBI ICU Core Study. 
After excluding patients with missing GCS at baseline (n = 133), pa- 
tients with no severe GCS (n = 1135), and patients that were in- 
cluded in countries that included less than 50 patients (n = 194), 
874 patients were included in this study.( Fig. 1 ) These patients 
were from three regions: Victoria, Australia (2 MTCs, n = 107), UK 
(8 MTCs, n = 171), and Europe (28 MTCs, n = 596, The Netherlands, 
Italy, Spain, Belgium, Norway, France each of which had > 50 patients 
enrolled and were included ). 
Patients with severe TBI in Victoria, Australia, compared to 
those in the UK and Europe, were younger (median: 32 (IQR: 23- 
48) vs 44 years (IQR: 27-56) and 44 years (IQR: 26 – 62), p:0.003), 
a higher proportion was injured due to a road traffic incident (60% 
vs 51% vs 55%, p < 0.001), and a lower proportion due to a fall (21% 
vs 31% vs 34%). Although a higher proportion of patients in Victo- 
ria, Australia and Europe than the UK, were transported direct to 
the trauma centre from the accident scene (90% vs 89% vs 66%) 
the transport times (from scene to trauma centre) for primary re- 
ferrals were similar (median: 97 (IQR: 64-151) vs 105 (IQR: 80 –
127) minutes) in Victoria, Australia and the UK, but shorter in Eu- 
rope (median: 73 (IQR: 54-100) minutes). In Australia, UK and Eu- 
rope, two thirds of severe TBI patients were intubated before hos- 
pital arrival (67% vs 60% vs 70%). However ICP monitors (75% vs 
74% vs 58%, p < 0.001), and intensive therapies (74% vs 71% vs 54%, 
p < 0.001) were used in a higher proportion of patients in Australia 
and UK than Europe. Patients’ brain injury severities expressed as 
GCS scores, and pupil reactivities were similar in all regions, but CT 
scans reported epidural hematomas in a higher proportion of pa- 
tients in Australia (p = 0.004), and contusions in a lower proportion 
of patients in Europe (p = 0.02). 
More patients in Victoria, Australia had secondary brain insults 
recorded in the prehospital and emergency room phases of care. 
In Australia compared to UK/Europe, hypotension was recorded in 
30% vs 17% / 21% (p = 0.03), and hypoxia in 28% vs 19% / 22%. 
(p = 0.23) Major extracranial injuries were observed in a lower pro- 
portion of patients in Australia than in the UK and Europe (59% vs 
61% vs 68%, p = 0.08), but thorax/chest injuries were observed in a 
higher proportion of patients in Australia. ( Table 1 , Table 2 ) 
Both extracranial surgeries and cranial surgeries were per- 
formed in more patients in Australia than in the UK and Europe 
(43% vs 20% vs 36%, p < 0.001 and 68% vs 50% vs 42%, p < 0.001), but 
most acute management medical practices were equivalent. Two 
interventions for refractory intracranial hypertension were used in 
a lower proportion of patients in Australia than the UK and Europe. 
These were intensive hypocapnia (1.1% vs 8.5% vs 6.7%) (p = 0.06), 
and decompressive craniectomy (14% vs 25% vs 15%) (p = 0.01). There 
were no differences in the proportion of patients with large in- 
tracranial hematomas (Marshall classification V/VI; 27% vs 41% vs 
34%). ( Table 2 ) 
However, despite the many similarities in other factors, ICU 
length of stay was substantially shorter in Australia than the UK 
and Europe, (median: 8.8 vs 13 days vs 11 days, p < 0.001), and 
hospital length of stay was shorter in Australia than in the UK, 
but similar to Europe (median 17 vs 23 vs 16 days, p < 0.001). In 
Australia although ICU times were shorter, most TBI deaths (19%) 
occurred in the ICU, and a further 3% occurred after ICU. In the UK, 
ICU mortality was 16%, with another 5% occurring later. In Europe, 
Fig. 1. Flowchart of included patients from the CENTER-TBI and OzENTER-TBI studies 
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Table 1 
Baseline characteristics of patients with severe TBI in Victoria, Australia, the UK and Europe 
VariableTotal 
number of patients AustraliaN = 107 UKN = 171 EuropeN = 596 p-value 
Demographic 
characteristics 
Age (median (IQR)) 32 (23 – 48) 44 (27 – 56) 44 (26 – 62) 0.003 
> 65 years 13 (12%) 26 (15%) 133 (22%) 0.01 
Male sex 84 (79%) 128 (75%) 448 (75%) 0.74 
Cause of injury < 0.001 
Road traffic 
incident 
64 (60%) 82 (51%) 320 (55%) 
Incidental fall 22 (21%) 50 (31%) 194 (34%) 
Suicide Attempt 6 (5.6%) 3 (1.9%) 18 (3.1%) 
Violence/Assault 9 (8.4%) 12 (7.4%) 6 (1.0%) 
Other 6 (5.6%) 15 (9.3%) 41 (7.1%) 
Missing - 9 17 
Clinical 
presentation 
GCS Motor Score - 
Baseline 
0.05 
1/2 51 (49%) 76 (46%) 306 (53%) 
3/4 16 (15%) 44 (27%) 134 (23%) 
5/6 38 (36%) 44 (27%) 143 (25%) 































32 (30%) 26 (17%) 120 (21%) 0.03 
Missing 0 13 19 
Any major 
extracranial injury 
(AIS > = 3) 
63 (59%) 105 (61%) 405 (68%) 0.08 
Spine 17 (16%) 36 (21%) 120 (20%) 0.54 
Thorax/Chest 57 (53%) 69 (40%) 262 (44%) 0.10 





28 (29%) 25 (19%) 81 (15%) 0.004 




69 (71%) 105 (80%) 423 (79%) 0.24 
Missing 10 39 57 
Contusion 29 (50%) 71 (69%) 204 (51%) 0.02 




I/II 59 (61%) 61 (46%) 276 (51%) 
III/IV 12 (12%) 18 (14%) 82 (21%) 
V/VI 26 (27%) 54 (41%) 184 (34%) 
Missing 10 38 54 
ANOVA was used for comparison of continuous variables across strata. The χ 2 test was used for comparison of cate- 
gorical variables. P values relate to how likely differences between groups could occur while no differences between 
groups exist. 
2% of hospital deaths occurred after ICU. In Australia, the median 
time from ICU admission to death in ICU was 4.1 days [IQR: 1.2 –
8.9] and the median time from ICU admission to decision of with- 
drawal of treatment was 3.7 days [IQR: 1.3 – 7.8], compared to 7.1 
days [IQR: 3.1 – 13] and 8.0 [IQR: 2.5 – 12] in the UK, and 1.7 days 
[IQR: 0.6 – 6.4] and 1.1 [IQR: 0.3 – 4.6] days in Europe (p = 0.01 
and p < 0.01). Withdrawal of therapy due to very severe brain injury 
was the primary cause of death in both countries (91% in Australia 
vs 89% in the UK). In Australia 64% of TBI patients were discharged 
to a rehabilitation centre compared to 26% in UK and 28% in Eu- 
rope (P < 0.001) where the most common discharge destination was 
a second hospital. 
GOSE at 6 months was available in 776 (89%) patients. The 
follow-up rate was higher in Victoria (n = 99, 93%), compared to UK 
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Table 2 
Management characteristics of patients with severe TBI in Victoria, Australia, the UK and Europe 
VariableTotal 
number of patients AustraliaN = 107 UKN = 171 EuropeN = 596 p-value 
Referral 
Primary referral 96 (90%) 113 (66%) 531 (89%) < 0.001 





(64 – 151) 
105 
(80 – 127) 
73 
(54 – 100) 
0.70 
Secondary referral 11 (10%) 58 (34%) 65 (11%) < 0.001 





(308 – 512) 
325 
(239 – 499) 
308 





Arrived Intubated 71 (67%) 102 (60%) 416 (70%) 0.04 
Missing 1 - 2 
ICP monitor placed 80 (75%) 126 (74%) 343 (58%) < 0.001 
Cranial Surgery 72 (68%) 85 (50%) 248 (42%) < 0.001 
Missing 1 1 1 
Extracranial 
Surgery 
45 (43%) 35 (20%) 215 (36%) < 0.001 





79 (74%) 121 (71%) 319 (54%) < 0.001 
Mechanical 
Ventilation for at 
least 24 hours 




106 (99%) 163 (96%) 545 (92%) 0.01 
Missing - 1 2 
Hypothermia < 35 
°C 
15 (16%) 24 (15%) 61 (11%) 0.21 
Missing 13 6 32 
Mild Hypothermia 
with a lower limit 
of 35 °C 
23 (24%) 48 (29%) 67 (12%) < 0.001 
Missing 13 6 32 
Intensive 
Hypocapnia 
[PaCO2 < 4.0 kPa 
(30 mmHg)] 
1 (1.1%) 14 (8.5%) 38 (6.7%) 0.06 
Missing 13 6 32 
Metabolic 
Suppression ∗∗
23 (24%) 40 (24%) 183 (32%) 0.06 
Missing 13 6 32 
Paralysis 54 (57%) 88 (53%) 171 (30%) < 0.001 
Missing 13 6 32 
Decompressive 
craniectomy 
13 (14%) 41 (25%) 84 (15%) 0.01 
Missing 13 6 32 
ANOVA was used for comparison of continuous variables across strata. The χ 2 test was used for comparison of cate- 
gorical variables. P values relate to how likely differences between groups could occur while no differences between 
groups exist. 
∗ A combination of ICP Monitor, Invasive Blood Pressure Monitoring, and Mechanical Ventilation for at least 24 hours 
∗∗ Metabolic suppression for ICP control with high dose barbiturates or propofol 
(n = 135, 79%) and similar to Europe (n = 542, 91%). Six-month mor- 
talities were 24% vs 30% vs 28%.( Table 3 ). Overall, six-month mor- 
tality was better than predicted (27% vs 35%, observed to expected 
ratio 0.77 [95% CI: 0.64 – 0.87]), and similar in Victoria, UK and 
Europe (0.86 [95% CI: 0.49–1.23] vs 0.82 [0.51–1.15] vs 0.76 [0.60–
0.87]). In all 3 regions however, unfavourable non-independent 
functional outcomes measured by GOSE < = 4 were similar to pre- 
dicted (1.32 [0.96-1.86] vs 1.13 [0.84-1.42] vs 0.96 [0.85-1.09]). Un- 
adjusted unfavourable outcomes rates exceeded 50% (63% vs 65% 
vs 55%). The unadjusted proportion of survivors with severe dis- 
ability at 6 months was similar in Australia and the UK (51% and 
50%), compared to 37% in Europe ( Table 3 ). The observed to ex- 
pected ratios after multiple imputation were similar to those in 
complete case analysis. (Supplemental Table 1) 
Discussion 
Compared to TBI patients in the UK, and Europe, patients in 
Victoria, Australia were younger, and higher proportions had road 
traffic incidents compared to falls, secondary insults in the pre- 
hospital and emergency phases of care (predominantly hypoten- 
sion), and epidural hematomas. A lower proportion received in- 
tensive hypocapnia and decompressive craniectomy therapies, and 
the patients treated in Victoria had shorter times to withdrawal of 
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Table 3 
Outcomes among patients with severe TBI in Victoria, Australia, the UK and Europe 
Variable 
Total number of 
patients 
Australia 
N = 107 
UK 
N = 171 
Europe 
N = 596 
P-value 
Length of Stay 









(1.8 – 33) 
< 0.001 
Hospital Length of 
stay for all patients 
who survived to 
hospital discharge, 
median (IQR) - 
days 
19 
( 11 – 32 ) 
30 
( 12 – 60) 
22 
(8.6 – 38) 
< 0.001 




(4.6 – 15) 
13 
(5.6 – 20) 
11 
(3.2 – 21) 
< 0.05 
ICU Length of stay 
for all patients 





(4.9 – 16) 
14 
(7.4 – 22) 
14 
(5.6 – 23) 
0.02 
Hospital Mortality 
ICU Mortality 20 (19%) 28 (16%) 124 (21%) 0.39 
In-hospital 
Mortality 
24 (22%) 36 (21%) 139 (23%) 0.82 
Cause of Death (for 










4 (17%) 8 (32%) 15 (14%) 




- 2 (8%) 9 (8,4%) 































24 (24%) 41 (30%) 154 (28%) 0.58 








0.86 [0.49 – 1.23] 0.82 [0.51 – 1.15] 0.76 [0.60 – 0.87] 0.72 
6-months 
unfavourable 
outcome (GOSE < 5) 
62 (63%) 88 (65%) 297 (55%) 0.05 










1.32 [0.96 – 1.68] 1.13 [0.84 – 1.42] 0.96 [0.85 – 1.09] 0.10 
6-month GOSE 2-4 
vs 5-8 
38 (51%) 47 (50%) 143 (37%) 0.01 
The χ2 test was used for comparison of categorical variables. P values relate to how likely differences between groups 
could occur while no differences between groups exist. The outcome comparisons with the IMPACT CT model were 
based on patients in whom both information on predicted outcome and observed outcome was available. A chi-squared 
goodness of fit was applied to the observed versus expected values. 
∗ Length of stay was missing in: 0, 7, 12 patients. 
∗∗ according to the IMPACT-CT model. ANOVA was used for comparison of continuous variables across strata. 6 
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therapy for severe brain injuries, contributing to shorter ICU and 
hospital times. The proportion discharged to rehabilitation centres 
in Victoria was greater than UK and Europe but at 6 months af- 
ter injury, mortality and functional outcomes in all 3 regions were 
similar, with unfavourable non-independent living being similar to 
IMPACT predictions. 
The younger age of severe TBI patients in Victoria, Australia 
compared to the UK, likely reflects patient selection within the Vic- 
torian Trauma system, which directs adult trauma patients prefer- 
entially to two adult trauma centres, but triages patients 65 years 
old and over with an isolated TBI related to a low fall, to different 
neurosurgical centres that did not participate in the OzENTER-TBI. 
A recent Registry study in Victoria of severe TBI patients reported a 
85%:15% patient division between the two major trauma centres of 
our study and the other hospitals with neurological services, and 
also a median age of severe TBI patients in the whole state of 41.5 
years.( 14 ) which is comparable to the UK (44 years), but different 
to this study (32 years). Selection in Victoria also likely accounts 
for the lower proportion of falls compared to UK which are more 
common in the elderly, and the higher rate of road traffic inci- 
dents (60% vs 50%). The higher rates of hypotension and hypoxia 
in Australia may relate to the higher percentage of road traffic in- 
cidents in this cohort, with associated greater haemorrhage and 
thoracic injuries. Our data suggest they are not due to different 
prehospital intubation rates nor to longer transport times, however 
they are likely to impact upon patient outcomes. Future research in 
Australia may optimally be directed towards further improvements 
in fluid resuscitation and intubation protocols aimed at reducing 
these secondary insults. ( 20 , 21 ) 
We found large variation between Australia, the UK and Eu- 
rope in the use of brain-specific treatments including ICP mon- 
itoring, metabolic suppression, intensive hypocapnia, and paraly- 
sis. Intensive hypocapnia is little used in Australia due to concerns 
about short duration of action, and possible adverse implications of 
cerebral vasoconstriction. Several attempts to improve the quality 
of evidence for ICP monitoring have been performed in the past, 
which have been complicated by ethical challenges in randomiz- 
ing patients between ICP monitoring and no ICP monitoring, and 
result in low evidence recommendations.( 22 , 23 ) Recent develop- 
ments in technology resulted in new monitoring techniques, also 
known as multimodal monitoring, that can provide the neuro in- 
tensivist with information and assist in management decision mak- 
ing.( 24 , 25 ) Currently, several collaborations and research efforts 
are being made to resolve the outstanding questions about the 
roles and indications for neuro monitoring after TBI and demon- 
strate unequivocally whether monitor-guided interventions lead to 
improved outcomes for patients.( 26 ) Another therapeutic option is 
decompressive craniectomy, which we found to be less common in 
Australia and Europe than the UK (P = 0.01). A current randomised 
trial is testing decompressive craniectomy after evacuation of in- 
tracranial hematomas for brain swelling, but in patients with dif- 
fuse severe TBI and combined diffuse and mass lesion TBI, two 
large randomised trials in 2011 and 2016 found that decompressive 
craniectomy increased severely disabled survivors at 6 months. At 
12 months, neither study showed an increase in patients surviving 
with a GOSE ≥ 5.( 7 , 8 , 27 , 28 ) 
ICU and hospital times were 50% shorter for TBI patients in Aus- 
tralia than the UK. Since dying patients consume less hospital time 
than survivors, timing of death impacts these findings, and in Aus- 
tralia almost all TBI deaths occurred during the first 9 days in ICU. 
In the UK, ICU stays were longer, yet one third of UK deaths oc- 
curred after ICU. It is possible that some of these differences may 
be because step down care of critically ill patients may have been 
differentially labelled as ICU or non-ICU care in different hospitals, 
but such details were unavailable. Since 80% of TBI deaths in both 
countries were due to such severe head injury that withdrawal of 
care took place, the unexpected difference in timings of this de- 
cision making may be a factor driving reduced hospital times and 
costs in Australia, compared to the UK. 
A higher proportion of patients was discharged to rehabilitation 
facilities in Victoria than in the comparable countries where a sec- 
ond (less acute) hospital was most common, although this might 
be explained in part by the younger age of patients in Victoria. 
However, availability of rehabilitation services in Victoria for road 
trauma patients who are compensable through the Transport Acci- 
dent Commission, may be another driver.( 29 ) Lower level RCT evi- 
dence and expert opinion suggest that TBI rehabilitation is benefi- 
cial in improving the functional outcomes beyond what we would 
expect from spontaneous recovery.( 30 , 31 ) However, the probabil- 
ity of receiving rehabilitation is associated with patients’ and re- 
gional characteristics. Also, it might be challenging to meet the key 
success criteria for health and rehabilitation services such as inclu- 
sion of and access to and inclusion of well-coordinated multidis- 
ciplinary processes incorporating the varying needs of the individ- 
uals having sustained a TBI. However, our results may also ques- 
tion the beneficial impact of earlier rehabilitation on long term 
functional outcomes in severe TBI patients. Therefore, future stud- 
ies should assess the necessity of more extensive multidimensional 
and standardized assessment of functional and psychological im- 
pairments and corresponding rehabilitation needs. 
However despite these differences, after adjusting for predicted 
outcomes using IMPACT CT, patient outcomes at 6 months in all 
three regions were very similar: mortality tended to be better than 
predicted, but independent outcomes were not, indicating that the 
number of people living with severe disability was increased com- 
pared to predicted in all regions. Also, we did not observe any sub- 
stantial differences in outcome between Victoria, Australia, the UK 
and Europe, confirming the results of a recent study. ( 32 ) Although 
this could be the result of a homogenous standard of treatment in 
the three regions, this might also suggest that the differences in 
therapies may be discordant and urges the need for future studies 
that study the effect of these therapies in isolation. The IMPACT CT 
prognostic scheme accounts for only about a third of outcome vari- 
ance, and outcomes in all three regions may have been affected by 
unmeasured confounders. This, coupled with the large confidence 
intervals for our estimates of observed/expected unfavourable out- 
come in Victoria and the UK may mean that significant differences 
were missed. 
Strengths of this study were the enrollment of patients with se- 
vere TBI across three large regions and many countries, and the de- 
tailed information on demographics, therapies, and outcomes. Lim- 
itations were first that our three cohorts were a small proportion 
of all patients with TBI in Australia, UK, and Europe, and they were 
not enrolled consecutively which could introduce selection bias. 
Second, follow-up data was missing in some patients, adding some 
uncertainty to the interpretation of the outcome comparisons. 
This study highlights regional differences in patient characteris- 
tics which need to be considered when interpreting and compar- 
ing results from clinical studies on TBI from different regions. This 
collaboration within the InTBIR initiative will enable future meta- 
analyses for research questions that require larger numbers. Results 
from observational studies may give rise to new insights in disease 
mechanisms and rejuvenate industry interests and investment in 
TBI. 
In conclusion, differences exist in case-mix between Victoria, 
Australia compared to the UK and Europe, including a younger age 
and a higher rate of secondary brain insults. Despite some differ- 
ences in management and discharge policies, mortality and func- 
tional outcomes are largely similar. Contemporary mortality is bet- 
ter than expected based on historical data, but independent living 
outcomes may not have improved. These findings are likely driven 
by increased survival with disability over time and emphasize the 
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Fig. 2. Probabilities of state of severe TBI patients during the first two weeks after ICU admission. The x-axis represents time from ICU admission in hours, y-axis represents 
the probability to be in one the following states; discharged from ICU, still in ICU, or died in ICU. 
need for further global efforts in order to refine recommendations 
for severe TBI patients. 
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Cecilia Åkerlund 1 , Krisztina Amrein 2 , Nada Andelic 3 , Lasse 
Andreassen 4 , Audny Anke 5 , Anna Antoni 6 , Gérard Audibert 7 , 
Philippe Azouvi 8 , Maria Luisa Azzolini 9 , Ronald Bartels 10 , 
Pál Barzó11 , Romuald Beauvais 12 , Ronny Beer 13 , Bo-Michael 
Bellander 14 , Antonio Belli 15 , Habib Benali 16 , Maurizio Berardino 17 , 
Luigi Beretta 9 , Morten Blaabjerg 18 , Peter Bragge 19 , Alexandra 
Brazinova 20 , Vibeke Brinck 21 , Joanne Brooker 22 , Camilla Brorsson 23 , 
Andras Buki 24 , Monika Bullinger 25 , Manuel Cabeleira 26 , Alessio 
Caccioppola 27 , Emiliana Calappi 27 , Maria Rosa Calvi 9 , Peter 
Cameron 28 , Guillermo Carbayo Lozano 29 , Marco Carbonara 27 , 
Simona Cavallo 17 , Giorgio Chevallard 30 , Arturo Chieregato 30 , 
Giuseppe Citerio 31, 32 , Iris Ceyisakar 33 , Hans Clusmann 34 , Mark 
Coburn 35 , Jonathan Coles 36 , Jamie D. Cooper 37 , Marta Correia 38 , 
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